School openings across globe suggest ways to keep coronavirus at bay, despite outbreaks
Science explores reopening strategies from South Africa to Finland to Israel
Science explores reopening strategies from South Africa to Finland to Israel
Sponsored by: Cleerly, Women as One and International Atherosclerosis
Zealand Pharma said that its obesity candidate that uses a unique mechanism led to notable weight loss in an early trial.
FDA Launches Agency-Wide AI Tool
Nature – Options are emerging for the tens of millions of people who stop taking GLP-1 drugs because of side effects, cost or availability.
Nature – Options are emerging for the tens of millions of people who stop taking GLP-1 drugs because of side effects, cost or availability.
Metsera’s obesity drug candidate targeting the amylin hormone showed marked efficacy in an early trial, the company said
Metsera’s obesity drug candidate targeting the amylin hormone showed marked efficacy in an early trial, the company said
In the 1980s, atherothrombosis was definitively established as the most prevalent mechanism underlying acute coronary syndromes (ACS).1,2 In the 1990s, sin
FDA Launches Agency-Wide AI Tool
A study found that women could switch drugs without waiting for scans showing cancer progression, which improved their quality of life.